Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anna Karin Maltais"'
Autor:
Elizaveta Starodubova, Olga Krotova, David Hallengärd, Yulia Kuzmenko, Gunnel Engström, Diana Legzdina, Oleg Latyshev, Olesja Eliseeva, Anna Karin Maltais, Vera Tunitskaya, Vadim Karpov, Andreas Bråve, Maria Isaguliants
Publikováno v:
Molecular Imaging, Vol 11 (2012)
The efficient cell-mediated immune response clears cells expressing deoxyribonucleic acid (DNA) immunogens, but there are no methods to monitor this in vivo. We hypothesized that immune-mediated clearance can be monitored in vivo if DNA immunogens ar
Externí odkaz:
https://doaj.org/article/897be335bc7842948ed120a1e544abf8
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/3a4fe17b2bba48079e6d204a915d93e6
Autor:
Amineh Ghaderi, Fernanda Costa Svedman, Mahin Nikougoftar Zarif, Zahra Rajabkhani, Johan Liwing, Anna-Karin Maltais, Anders Ullén
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e9db0890b5a144fca3fd1941ec979328
Autor:
Anna-Karin Maltais, Gabriel P. Krestin, Edwin J. B. Veldhuis Kroeze, Albert D. M. E. Osterhaus, Hans Arwidsson, Geert van Amerongen, Alf A. Lindberg, Marcel L. Dijkshoorn, Jorma Hinkula, Koert J. Stittelaar
Publikováno v:
Vaccine, 32(26), 3307-3315. Elsevier
Influenza is a contagious respiratory disease caused by an influenza virus. Due to continuous antigenic drift of seasonal influenza viruses, influenza vaccines need to be adjusted before every influenza season. This allows annual vaccination with mul
Autor:
Anna-Karin Maltais, Sanna Nyström, Patricia L. Earl, Andreas Bråve, Steven E. Applequist, Britta Wahren, Bernard Moss, Mary A. Marovich, David Hallengärd, Kopek Nihlmark
Publikováno v:
Viral Immunology. 25:423-432
Heterologous priming and boosting with antigens expressed by DNA, viral vectors, or as proteins, are experimental strategies to induce strong immune responses against infectious diseases and cancer. In a preclinical study we compared the ability of r
Autor:
Britta Wahren, David Hallengärd, Andreas Bråve, B. Kristian Haller, Kopek Nihlmark, Eva Gelius, Anna-Karin Maltais
Publikováno v:
Clinical and Vaccine Immunology. 18:1577-1581
In vivoelectroporation (EP) has proven to significantly increase plasmid transfection efficiency and to augment immune responses after immunization with plasmids. In this study, we attempted to establish an immunization protocol using intradermal (i.
Autor:
G. Biberfeld, Anna-Karin Maltais, Eric Sandström, David Hallengärd, B. Kristian Haller, Urban Höglund, Richard Stout, Bo Hejdeman, Alan D. King, Britta Wahren, Andreas Bråve, Pontus Blomberg, Lindvi Gudmundsdotter
Publikováno v:
Vaccine
Vaccine; Vol 28
Vaccine; Vol 28
It is likely that gene-based vaccines will enter the human vaccine area soon. A few veterinary vaccines employing this concept have already been licensed, and a multitude of clinical trials against infectious diseases or different forms of cancer are
Publikováno v:
Vaccine. 31(37)
We tested safety, clinical efficacy and immunogenicity of a DNA vaccine coding for rhesus prostate specific antigen (PSA) delivered by intradermal injection and skin electroporation. Fifteen patients with biochemical relapse of prostate cancer withou
Autor:
Andreas Bråve, Sarah Petersson, Maria G. Isaguliants, B. Kristian Haller, David Hallengärd, Andreas Boberg, Britta Wahren, Anna-Karin Maltais
Publikováno v:
Vaccine. 29(4)
HIV-1 protease is an important target for anti-HIV therapy but has not received much attention as a vaccine antigen. To investigate the immunogenic properties of HIV-1 protease, we designed DNA plasmids encoding variants of the protease gene. Mutatio
Autor:
Oleg Latyshev, Vera L. Tunitskaya, Gunnel Engström, Maria G. Isaguliants, David Hallengärd, Vadim L. Karpov, Elizaveta Starodubova, Diana Legzdina, Yulia Kuzmenko, Anna Karin Maltais, Olga Krotova, Olesja Eliseeva, Andreas Bråve
Publikováno v:
Molecular Imaging, Vol 11 (2012)
The efficient cell-mediated immune response clears cells expressing deoxyribonucleic acid (DNA) immunogens, but there are no methods to monitor this in vivo. We hypothesized that immune-mediated clearance can be monitored in vivo if DNA immunogens ar